Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/110661
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorSchool of Nursing-
dc.creatorSun, HL-
dc.creatorChen, P-
dc.creatorBai, W-
dc.creatorZhang, L-
dc.creatorFeng, Y-
dc.creatorSu, Z-
dc.creatorCheung, T-
dc.creatorUngvari, GS-
dc.creatorCui, XL-
dc.creatorNg, CH-
dc.creatorAn, FR-
dc.creatorXiang, YT-
dc.date.accessioned2024-12-27T06:27:43Z-
dc.date.available2024-12-27T06:27:43Z-
dc.identifier.urihttp://hdl.handle.net/10397/110661-
dc.language.isoenen_US
dc.publisherNature Publishing Groupen_US
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en_US
dc.rights© The Author(s) 2024en_US
dc.rightsThe following publication Sun, HL., Chen, P., Bai, W. et al. Prevalence and network structure of depression, insomnia and suicidality among mental health professionals who recovered from COVID-19: a national survey in China. Transl Psychiatry 14, 227 (2024) is available at https://doi.org/10.1038/s41398-024-02918-8.en_US
dc.titlePrevalence and network structure of depression, insomnia and suicidality among mental health professionals who recovered from COVID-19 : a national survey in Chinaen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume14-
dc.identifier.doi10.1038/s41398-024-02918-8-
dcterms.abstractPsychiatric syndromes are common following recovery from Coronavirus Disease 2019 (COVID-19) infection. This study investigated the prevalence and the network structure of depression, insomnia, and suicidality among mental health professionals (MHPs) who recovered from COVID-19. Depression and insomnia were assessed with the Patient Health Questionnaire (PHQ-9) and Insomnia Severity Index questionnaire (ISI7) respectively. Suicidality items comprising suicidal ideation, suicidal plan and suicidal attempt were evaluated with binary response (no/yes) items. Network analyses with Ising model were conducted to identify the central symptoms of the network and their links to suicidality. A total of 9858 COVID-19 survivors were enrolled in a survey of MHPs. The prevalence of depression and insomnia were 47.10% (95% confidence interval (CI) = 46.09–48.06%) and 36.2% (95%CI = 35.35–37.21%), respectively, while the overall prevalence of suicidality was 7.8% (95%CI = 7.31–8.37%). The key central nodes included “Distress caused by the sleep difficulties” (ISI7) (EI = 1.34), “Interference with daytime functioning” (ISI5) (EI = 1.08), and “Sleep dissatisfaction” (ISI4) (EI = 0.74). “Fatigue” (PHQ4) (Bridge EI = 1.98), “Distress caused by sleep difficulties” (ISI7) (Bridge EI = 1.71), and “Motor Disturbances” (PHQ8) (Bridge EI = 1.67) were important bridge symptoms. The flow network indicated that the edge between the nodes of “Suicidality” (SU) and “Guilt” (PHQ6) showed the strongest connection (Edge Weight= 1.17, followed by “Suicidality” (SU) - “Sad mood” (PHQ2) (Edge Weight = 0.68)). The network analysis results suggest that insomnia symptoms play a critical role in the activation of the insomnia-depression-suicidality network model of COVID-19 survivors, while suicidality is more susceptible to the influence of depressive symptoms. These findings may have implications for developing prevention and intervention strategies for mental health conditions following recovery from COVID-19.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationTranslational psychiatry, 2024, v. 14, 227-
dcterms.isPartOfTranslational psychiatry-
dcterms.issued2024-
dc.identifier.scopus2-s2.0-85194997919-
dc.identifier.pmid38816419-
dc.identifier.eissn2158-3188-
dc.identifier.artn227-
dc.description.validate202412 bcch-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Scopus/WOSen_US
dc.description.fundingSourceOthersen_US
dc.description.fundingTextNational Science and Technology Major Project for Investigational New Drug; Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support; University of Macauen_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryCCen_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
s41398-024-02918-8.pdf1.61 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

30
Citations as of Apr 14, 2025

Downloads

1
Citations as of Apr 14, 2025

SCOPUSTM   
Citations

10
Citations as of Dec 19, 2025

WEB OF SCIENCETM
Citations

10
Citations as of Dec 18, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.